Skip to main content
Top
Published in: International Urogynecology Journal 6/2011

Open Access 01-06-2011 | Original Article

Prophylactic vesical instillations with 0.2% chondroitin sulfate may reduce symptoms of acute radiation cystitis in patients undergoing radiotherapy for gynecological malignancies

Authors: Menke H. Hazewinkel, Lukas J. A. Stalpers, Marcel G. Dijkgraaf, Jan-Paul W. R. Roovers

Published in: International Urogynecology Journal | Issue 6/2011

Login to get access

Abstract

Introduction and hypothesis

We studied the feasibility and efficacy of intravesical instillations with 40 ml chondroitin sulfate 0.2% solution to prevent or reduce acute radiation cystitis in women undergoing pelvic radiotherapy.

Methods

In a comparative pilot study in 20 patients, half of the patients received instillations. Instillations' bother was measured with visual analog scores (VAS, 0–10); bladder pain, with VAS; micturition-related quality of life, with the urogenital distress inventory (UDI).

Results

One of the instilled patients discontinued the instillations. The first median “acceptability”-VAS was 0 (range, 0–3); the last median was 1 (range, 0–3). “Bladder pain”-VAS peaked halfway in the treatment among controls (median, 1; range, 0–5) and after treatment in the instilled patients (median, 1; range, 1–3). UDI scores showed over time median follow-up scores at or above median baseline scores in controls and at or below median baseline scores in instilled patients.

Conclusion

Intravesical instillations with chondroitin sulfate 0.2% solution may decrease the bother related to bladder symptoms and are well tolerated.
Literature
1.
go back to reference Shakespeare TP, Lim KH, Lee KM, Back MF, Mukherjee R, Lu JD (2006) Phase II study of the American Brachytherapy Society guidelines for the use of high-dose rate brachytherapy in the treatment of cervical carcinoma: is 45–50.4 Gy radiochemotherapy plus 31.8 Gy in six fractions high-dose rate brachytherapy tolerable? Int J Gynecol Cancer 16(1):277–282PubMedCrossRef Shakespeare TP, Lim KH, Lee KM, Back MF, Mukherjee R, Lu JD (2006) Phase II study of the American Brachytherapy Society guidelines for the use of high-dose rate brachytherapy in the treatment of cervical carcinoma: is 45–50.4 Gy radiochemotherapy plus 31.8 Gy in six fractions high-dose rate brachytherapy tolerable? Int J Gynecol Cancer 16(1):277–282PubMedCrossRef
2.
go back to reference Yalman D, Arican A, Ozsaran Z, Celik OK, Yurut V, Esassolak M et al (2002) Evaluation of morbidity after external radiotherapy and intracavitary brachytherapy in 771 patients with carcinoma of the uterine cervix or endometrium. Eur J Gynaecol Oncol 23(1):58–62PubMed Yalman D, Arican A, Ozsaran Z, Celik OK, Yurut V, Esassolak M et al (2002) Evaluation of morbidity after external radiotherapy and intracavitary brachytherapy in 771 patients with carcinoma of the uterine cervix or endometrium. Eur J Gynaecol Oncol 23(1):58–62PubMed
3.
go back to reference Coyne KS, Sexton CC, Irwin DE, Kopp ZS, Kelleher CJ, Milsom I (2008) The impact of overactive bladder, incontinence and other lower urinary tract symptoms on quality of life, work productivity, sexuality and emotional well-being in men and women: results from the EPIC study. BJU Int 101(11):1388–1395PubMedCrossRef Coyne KS, Sexton CC, Irwin DE, Kopp ZS, Kelleher CJ, Milsom I (2008) The impact of overactive bladder, incontinence and other lower urinary tract symptoms on quality of life, work productivity, sexuality and emotional well-being in men and women: results from the EPIC study. BJU Int 101(11):1388–1395PubMedCrossRef
4.
go back to reference Maduro JH, Pras E, Willemse PH, de Vries EG (2003) Acute and long-term toxicity following radiotherapy alone or in combination with chemotherapy for locally advanced cervical cancer. Cancer Treat Rev 29(6):471–488PubMedCrossRef Maduro JH, Pras E, Willemse PH, de Vries EG (2003) Acute and long-term toxicity following radiotherapy alone or in combination with chemotherapy for locally advanced cervical cancer. Cancer Treat Rev 29(6):471–488PubMedCrossRef
5.
go back to reference Butrick CW (2000) Radiation cystitis. In: Howard FM, Perry CP, Carter JE, El-Minawi AM (eds) Pelvic pain: diagnosis and management, 1st edn. Williams and Wilkins, Baltimore Butrick CW (2000) Radiation cystitis. In: Howard FM, Perry CP, Carter JE, El-Minawi AM (eds) Pelvic pain: diagnosis and management, 1st edn. Williams and Wilkins, Baltimore
7.
go back to reference Butrick CW, Sanford D, Hou Q, Mahnken JD (2009) Chronic pelvic pain syndromes: clinical, urodynamic, and urothelial observations. Int Urogynecol J Pelvic Floor Dysfunct 20(9):1047–1053PubMedCrossRef Butrick CW, Sanford D, Hou Q, Mahnken JD (2009) Chronic pelvic pain syndromes: clinical, urodynamic, and urothelial observations. Int Urogynecol J Pelvic Floor Dysfunct 20(9):1047–1053PubMedCrossRef
8.
go back to reference Farquharson DI, Shingleton HM, Sanford SP, Soong SJ, Varner RE Jr, Hester S (1987) The short-term effect of pelvic irradiation for gynecologic malignancies on bladder function. Obstet Gynecol 70(1):81–84PubMed Farquharson DI, Shingleton HM, Sanford SP, Soong SJ, Varner RE Jr, Hester S (1987) The short-term effect of pelvic irradiation for gynecologic malignancies on bladder function. Obstet Gynecol 70(1):81–84PubMed
9.
go back to reference Jereczek-Fossa BA, Badzio A, Jassem J (2003) Factors determining acute normal tissue reactions during postoperative radiotherapy in endometrial cancer: analysis of 317 consecutive cases. Radiother Oncol 68(1):33–39PubMedCrossRef Jereczek-Fossa BA, Badzio A, Jassem J (2003) Factors determining acute normal tissue reactions during postoperative radiotherapy in endometrial cancer: analysis of 317 consecutive cases. Radiother Oncol 68(1):33–39PubMedCrossRef
10.
go back to reference Perez CA, Grigsby PW, Lockett MA, Chao KS, Williamson J (1999) Radiation therapy morbidity in carcinoma of the uterine cervix: dosimetric and clinical correlation. Int J Radiat Oncol Biol Phys 44(4):855–866PubMedCrossRef Perez CA, Grigsby PW, Lockett MA, Chao KS, Williamson J (1999) Radiation therapy morbidity in carcinoma of the uterine cervix: dosimetric and clinical correlation. Int J Radiat Oncol Biol Phys 44(4):855–866PubMedCrossRef
11.
go back to reference Kyker KD, Coffman J, Hurst RE (2005) Exogenous glycosaminoglycans coat damaged bladder surfaces in experimentally damaged mouse bladder. BMC Urol 5:4PubMedCrossRef Kyker KD, Coffman J, Hurst RE (2005) Exogenous glycosaminoglycans coat damaged bladder surfaces in experimentally damaged mouse bladder. BMC Urol 5:4PubMedCrossRef
12.
go back to reference Nordling J, van Ophoven A (2008) Intravesical glycosaminoglycan replenishment with chondroitin sulphate in chronic forms of cystitis. A multi-national, multi-centre, prospective observational clinical trial. Arzneimittelforschung 58(7):328–335PubMed Nordling J, van Ophoven A (2008) Intravesical glycosaminoglycan replenishment with chondroitin sulphate in chronic forms of cystitis. A multi-national, multi-centre, prospective observational clinical trial. Arzneimittelforschung 58(7):328–335PubMed
13.
go back to reference Steinhoff G, Ittah B, Rowan S (2002) The efficacy of chondroitin sulfate 0.2% in treating interstitial cystitis. Can J Urol 9(1):1454–1458PubMed Steinhoff G, Ittah B, Rowan S (2002) The efficacy of chondroitin sulfate 0.2% in treating interstitial cystitis. Can J Urol 9(1):1454–1458PubMed
14.
go back to reference van der Vaart CH, de Leeuw JR, Roovers JP, Heintz AP (2003) Measuring health-related quality of life in women with urogenital dysfunction: the urogenital distress inventory and incontinence impact questionnaire revisited. Neurourol Urodyn 22(2):97–104PubMedCrossRef van der Vaart CH, de Leeuw JR, Roovers JP, Heintz AP (2003) Measuring health-related quality of life in women with urogenital dysfunction: the urogenital distress inventory and incontinence impact questionnaire revisited. Neurourol Urodyn 22(2):97–104PubMedCrossRef
15.
go back to reference Roovers JP, van der Bom JG, Huub van der Vaart C, Fousert DM, Heintz AP (2001) Does mode of hysterectomy influence micturition and defecation? Acta Obstet Gynecol Scand 80(10):945–951PubMedCrossRef Roovers JP, van der Bom JG, Huub van der Vaart C, Fousert DM, Heintz AP (2001) Does mode of hysterectomy influence micturition and defecation? Acta Obstet Gynecol Scand 80(10):945–951PubMedCrossRef
16.
go back to reference Jackson KS, Naik R (2006) Pelvic floor dysfunction and radical hysterectomy. Int J Gynecol Cancer 16(1):354–363PubMedCrossRef Jackson KS, Naik R (2006) Pelvic floor dysfunction and radical hysterectomy. Int J Gynecol Cancer 16(1):354–363PubMedCrossRef
Metadata
Title
Prophylactic vesical instillations with 0.2% chondroitin sulfate may reduce symptoms of acute radiation cystitis in patients undergoing radiotherapy for gynecological malignancies
Authors
Menke H. Hazewinkel
Lukas J. A. Stalpers
Marcel G. Dijkgraaf
Jan-Paul W. R. Roovers
Publication date
01-06-2011
Publisher
Springer-Verlag
Published in
International Urogynecology Journal / Issue 6/2011
Print ISSN: 0937-3462
Electronic ISSN: 1433-3023
DOI
https://doi.org/10.1007/s00192-010-1357-0

Other articles of this Issue 6/2011

International Urogynecology Journal 6/2011 Go to the issue